Regarding protein expression, densitometric studies of PLP1 in the same region revealed a significant decrease in PLP1 immunoreactivity at early stages of AD, which became more marked at middle stages, followed by a slight increase without reaching MA values at advanced stages of AD. The gene discussed is PLP1; the disease is Alzheimer disease.